Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription

Articles published in
Cancer Res
    May 2024
  1. JONES RT, Scholtes M, Goodspeed A, Akbarzadeh M, et al
    NPEPPS Is a Druggable Driver of Platinum Resistance.
    Cancer Res. 2024;84:1699-1718.
    >> Share

    March 2024
  2. HOSNI S, Kilian V, Klumper N, Gabbia D, et al
    Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma.
    Cancer Res. 2024;84:725-740.
    >> Share

    November 2023
  3. ZHAO Y, Chen J, Zheng H, Luo Y, et al
    SUMOylation-driven mRNA circularization enhances translation and promotes lymphatic metastasis of bladder cancer.
    Cancer Res. 2023 Nov 22. doi: 10.1158/0008-5472.CAN-23-2278.
    >> Share

    September 2023
  4. OUYANG Y, Ou Z, Zhong W, Yang J, et al
    FGFR3 alterations in bladder cancer stimulate serine synthesis to induce immune-inert macrophages that suppress T-cell recruitment and activation.
    Cancer Res. 2023 Sep 28. doi: 10.1158/0008-5472.CAN-23-1065.
    >> Share

    April 2023
  5. OWCZAREK TB, Kobayashi T, Ramirez R, Rong L, et al
    Correction: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.
    Cancer Res. 2023;83:1159.
    >> Share

    March 2023
  6. ZHUANG J, Shen L, Li M, Sun J, et al
    Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance.
    Cancer Res. 2023 Mar 20:CAN-22-2213. doi: 10.1158/0008-5472.CAN-22-2213.
    >> Share

  7. ZHANG L, Li Y, Zhou L, Zhou H, et al
    The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response.
    Cancer Res. 2023 Mar 20:CAN-22-2485. doi: 10.1158/0008-5472.CAN-22-2485.
    >> Share

  8. XIE R, Cheng L, Huang M, Huang L, et al
    NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer.
    Cancer Res. 2023 Mar 20:CAN-22-2233. doi: 10.1158/0008-5472.CAN-22-2233.
    >> Share

    February 2023
  9. CASWELL D, Swanton C
    Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer.
    Cancer Res. 2023;83:487-488.
    >> Share

    January 2023
  10. QIU H, Makarov V, Bolzenius JK, Halstead A, et al
    KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer.
    Cancer Res. 2023 Jan 13:CAN-22-1444. doi: 10.1158/0008-5472.CAN-22-1444.
    >> Share

    December 2022
  11. KUMAR B, Koul S, Petersen J, Khandrika L, et al
    Editor's Note: p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity.
    Cancer Res. 2022;82:4696.
    >> Share

  12. LIU W, Newhall KP, Khani F, Barlow L, et al
    The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer.
    Cancer Res. 2022 Dec 8:CAN-22-2912. doi: 10.1158/0008-5472.CAN-22-2912.
    >> Share

    May 2022
  13. NI Z, Sun P, Zheng J, Wu M, et al
    JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Cancer Res. 2022;82:1789-1802.
    >> Share

    April 2022
  14. AN M, Zheng H, Huang J, Lin Y, et al
    Aberrant Nuclear Export of circNCOR1 Underlies SMAD7-Mediated Lymph Node Metastasis of Bladder Cancer.
    Cancer Res. 2022 Apr 8. pii: 694333. doi: 10.1158/0008-5472.CAN-21-4349.
    >> Share

    January 2022
  15. WANG Y, Zhang Y, Li PC, Guo J, et al
    Development of novel aptamer-based targeted chemotherapy for bladder cancer.
    Cancer Res. 2022 Jan 21. pii: 0008-5472.CAN-21-2691.
    >> Share

  16. BELLAT V, Michel AO, Thomas C, Stokol T, et al
    A urinary drug-disposing approach as an alternative to intravesical chemotherapy for treating non-muscle invasive bladder cancer.
    Cancer Res. 2022 Jan 17. pii: 0008-5472.CAN-21-2897.
    >> Share

    December 2021
  17. XIA Y, Wang X, Liu Y, Shapiro E, et al
    PKM2 is essential for bladder cancer growth and maintenance.
    Cancer Res. 2021 Dec 13. pii: 0008-5472.CAN-21-0403.
    >> Share

    November 2021
  18. JING W, Wang G, Cui Z, Xiong G, et al
    FGFR3 Destabilizes PD-L1 Via NEDD4 to Control T Cell-Mediated Bladder Cancer Immune Surveillance.
    Cancer Res. 2021 Nov 9. pii: 0008-5472.CAN-21-2362.
    >> Share

    October 2021
  19. WEI W, Sun J, Zhang H, Xiao X, et al
    Circ0008399 interaction with WTAP promotes assembly and activity of the m6A methyltransferase complex and promotes cisplatin resistance in bladder cancer.
    Cancer Res. 2021 Oct 26. pii: 0008-5472.CAN-21-1518.
    >> Share

    September 2021
  20. YANG L, Sun J, Li M, Long Y, et al
    Oxidized low-density lipoprotein links hypercholesterolemia and bladder cancer aggressiveness by promoting cancer stemness.
    Cancer Res. 2021 Sep 3. pii: 0008-5472.CAN-21-0646.
    >> Share

  21. PARK S, Rong L, Owczarek TB, Di Bernardo M, et al
    Novel mouse models of bladder cancer identify a prognostic signature associated with risk of disease progression.
    Cancer Res. 2021 Sep 1. pii: 0008-5472.CAN-21-1254.
    >> Share

    April 2021
  22. FUHRMAN BJ, Moore SC, Byrne C, Makhoul I, et al
    Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts.
    Cancer Res. 2021;81:2246-2255.
    >> Share

    March 2021
  23. WULLWEBER A, Strick R, Lange F, Sikic D, et al
    Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling.
    Cancer Res. 2021;81:1552-1566.
    >> Share

  24. SOTTNIK JL, Vanderlinden LA, Joshi M, Chauca-Diaz A, et al
    Androgen Receptor Regulates CD44 Expression in Bladder Cancer.
    Cancer Res. 2021 Mar 9. pii: 0008-5472.CAN-20-3095.
    >> Share

    November 2020
  25. DOMINGUEZ GUTIERREZ PR, Kwenda EP, Donelan W, O'Malley P, et al
    Hyal2 expression in tumor-associated myeloid cells mediates cancer-related inflammation in bladder cancer.
    Cancer Res. 2020 Nov 25. pii: 0008-5472.CAN-20-1144.
    >> Share

    July 2020
  26. KIKUCHI H, Maishi N, Annan DA, Alam MT, et al
    Chemotherapy-Induced IL8 Upregulates MDR1/ABCB1 in Tumor Blood Vessels and Results in Unfavorable Outcome.
    Cancer Res. 2020;80:2996-3008.
    >> Share

  27. BUI NHB, Napoli M, Davis AJ, Abbas HA, et al
    Spatiotemporal Regulation of DeltaNp63 by TGFbeta-Regulated miRNAs Is Essential for Cancer Metastasis.
    Cancer Res. 2020;80:2833-2847.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016